Print Page     Close Window     

SEC Filings

SC 13G
ALTIUM CAPITAL MANAGEMENT LP filed this Form SC 13G on 02/08/2019
Entire Document
 
 

 

CUSIP No . 81577F109   Page 3 of 7

 

1

NAME OF REPORTING PERSONS
Altium Growth Fund, LP

 

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
(ENTITIES ONLY) EIN: 82-2105101

 
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) ☐

(b)

3 SEC USE ONLY  
4

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware, United States of America

 

NUMBER OF
SHARES

BENEFICIALLY
OWNED BY

EACH
REPORTING

PERSON
WITH:

5

SOLE VOTING

0

 
6

SHARED VOTING POWER

228,676 shares of Common Stock

182,941 shares of Common Stock issuable upon exercise of Series A Warrants (See Item 4) *

 
7

SOLE DISPOSITIVE POWER

0

 
8

SHARED DISPOSITIVE POWER

228,676 shares of Common Stock

182,941 shares of Common Stock issuable upon exercise of Series A Warrants (See Item 4) *

 
9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

228,676 shares of Common Stock

182,941 shares of Common Stock issuable upon exercise of Series A Warrants (See Item 4) *

 
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES
11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

6.61% (See Item 4) *

 
12

TYPE OF REPORTING PERSON

PN

 
         

 

 

 

© Apricus Biosciences, Inc.